Ads
-
Related paper
- Plasminogen Activator Inhibitor Type 2 in Human Tears and Blood during Pregnancy
- THE MAINTENANCE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN BLOOD SERUM IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
- Correlation between Inflammation and Fibrinolysis in Hypertensive Centrally Obese Subjects: A Study on C-Reactive Protein, Plasminogen Activator Inhibitor-1 and Thrombin Activatable Fibrinolysis Inhibitor
- Recurrent branch retinal arterial occlusions associated with plasminogen activator inhibitor-1 mutation
- Vector Delivery-Dependant Effect of Human Tissue Plasminogen Activator Signal Peptide on Vaccine Induction of T Cells
- BIOTECHNOLOGICAL PRODUCTION OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR PROTEIN & ITS APPLICATION
- PRODUCTION AND CHARACTERIZATION OF ANTIBODIES TO TISSUE PLASMINOGEN ACTIVATOR: APPLICATION FOR THE PLATELET FLOW CYTOMETRY ASSAY
- Effect of Tissue Plasminogen Activator on Treatment Outcome and Neuronal Degeneration in Acute Ischemic Stroke
- Alteration of the Methylation Status of Urokinase Plasminogen Activator (uPA) is involved in Proliferation and Invasion of Nasopharyngeal Cancer Cells
- USE OF SERUM SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR TO IDENTIFY SEVERITY OF LIVER FIBROSIS AND ACTIVITY IN CHRONIC VIRAL HEPATITIS C PATIENTS